Amid tough generics market, Sandoz to lay off 213 and shutter Eon Labs plant in North Carolina

Roughly an eon ago in the pharma industry (read: 20 years), Sandoz carved out a sizable generics foothold through dual mergers with Germany’s Hexal and U.S.-based Eon Labs. Now, the Swiss manufacturing giant is mothballing one of the latter company’s main facilities.